Item 1.01 Entry into a Material Definitive Agreement.
Amendment to Investor's Rights Agreement
On
The foregoing description of the IRA does not purport to be complete and is qualified in its entirety by reference to the IRA, a copy of which has previously been filed as Exhibit 10.1 to the Company's Registration Statement on Form S-1 (File No. 333-252083) and incorporated by reference herein.
The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 10.1 hereto and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Description
No. 10.1 Amendment No. 1 to the Amended and Restated Investor's Rights Agreement, datedJanuary 10, 2023 , by and betweenLandos Biopharma, Inc. and the investors that are a party thereto 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source